Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Breast Neoplasms 29Pain, Postoperative 10Colorectal Neoplasms 10Neoplasms 8Brain Neoplasms 8Stomach Neoplasms 7Prostatic Neoplasms 6Lung Neoplasms 6Pancreatic Neoplasms 5Melanoma 5Ovarian Neoplasms 4Hemorrhage 4Head and Neck Neoplasms 4Agnosia 4Rectal Neoplasms 3Neurotoxicity Syndromes 3Nasopharyngeal Carcinoma 3Myoma 3Multiple Endocrine Neoplasia Type 1 3Meningioma 3Lymphoma, Non-Hodgkin 3Leiomyoma 3Glioblastoma 3Delirium 3Colonic Neoplasms 3Chronic Pain 3Warts 2Uterine Cervical Neoplasms 2Stomatitis 2Skin Neoplasms 2

Interventions

Temozolomide 2Sodium Chloride 2Dexmedetomidine 2tucatinib 1tipifarnib 1sagopilone 1pembrolizumab 1Trastuzumab 1Tissue Banks 1Saline Solution 1Rituximab 1Radiotherapy 1Radiation 1Dasatinib 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Central Nervous System Diseases × Sodium Chloride × Clear all
NCT04399343 2021-01-28

DEPOD

Capital Medical University

Phase 4 Unknown
700 enrolled
CNS

Central Nervous System Diseases, Delirium

NCT04494828 2021-01-12

Impact Dexmedetomidine on Postoperative Delirium in Patients After Intracranial Operation for Brain Tumor

Capital Medical University

Phase 4 Completed
60 enrolled
CNS

Central Nervous System Diseases, Delirium

Data powered by HemOnc (CC BY 4.0) Colophon âš¡